BASF’s Omega-3 business was created following the BASF acquisition of Norwegian company ProNova BioPharma in 2013. We are a global leader in pharmaceutical, nutrition and medical foods Omega-3 categories and have been pioneering Omega-3 technology in Norway since 1838.
Our mission is to enable people to live stronger and longer by exclusive dedication to developing the world's most effective and proven Omega-3 solutions.
In the last five years, BASF has established a dedicated team and set of capabilities with the objective of combining leading science and consumer insight to commercialize breakthrough Omega-3 technology for the dietary supplement category.
BASF is the pioneer and world leader in high-concentrate omega-3 fatty acids for pharmaceuticals, dietary supplements and medical foods. Our leadership is built on our unique R&D capabilities for lipids, omega-3 derivates and development of omega-3 fatty acid formulations, as well as our worldwide safety and efficacy data. Combining leading science and consumer insights to commercialize breakthrough omega-3 technologies that improve health and save lives, BASF is dedicated to developing the world's most effective and proven omega-3 solutions for a longer and healthier life.
Interested to learn more about Accelon™ and our other Omega-3 innovations?
Our team travel regularly to meet customers, attend conferences and trade shows and would be delighted to meet you in person.
We also collaborate on projects with brand and R&D teams, researchers, health care professionals and key opinion leaders in the quest for future Omega-3 innovations. If you share our passion for Omega-3, have an idea and want to discuss further, please get in touch.
